Join the club for FREE to access the whole archive and other member benefits.

Ian White

CEO/CSO of Neobiosis and VP of The American College of Regenerative Medicine

Dr. White is considered a leading expert in the field of aging and regenerative medicine with 20 years’ experience working with stem cells, regenerative cells and tissue regeneration. Dr. White received his BS and MS from Liverpool University, England prior to being hired at Dartmouth college to study the genetics of gamete biology. From there Dr. White was recruited to Harvard University to work with hematopoietic stem cells (HSC) and immune cell biology where he co-authored several high impact peer-reviewed scientific manuscripts on the subject. Dr. White went on to receive his Ph.D. from the Ansary Stem Cell Institute, Division of Regenerative Medicine at Cornell University. Subsequently, Dr. White relocated to the Interdisciplinary Stem Cell Institute at the University of Miami’s Miller School of Medicine where he published ground-breaking research on the role of peripheral nerve signaling in cardiac regeneration. Dr. White currently sits as the CEO and CSO of NeoBiosis, LLC a perinatal regenerative tissue research and manufacturing CDMO facility, and serves as the vice president and member of the board of directors of the American College of Regenerative Medicine. Dr White is the co-founder of the Space-Aging Research Institute.

Visit website: https://www.neobiosis.com/ian-bio

 ian-white-phd

 DrIanWhite1

See also: Company Neobiosis - Clinical stage CDMO focused on tissues, cells and EVs from perinatal sources for use in regenerative medicine

Details last updated 30-Mar-2023

Ian White is also referenced in the following:

HEALinc Future Health Summit 2023

17-Apr-2023 to 19-Apr-2023

3-day health summit encouraging unique networking opportunities for industry professionals organized by The HEALinc